fluorodeoxyglucose f18 has been researched along with Glucose Metabolic Disorder in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (33.33) | 29.6817 |
| 2010's | 10 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Behen, ME; Chugani, HT; Govil-Dalela, T; Hicks, MA; Juhász, C; Kumar, A; Luat, A | 1 |
| Buchert, R; Euskirchen, P; Koch, A; Schreiber, SJ; Schulz-Schaeffer, WJ; Sobesky, J | 1 |
| Bleasel, AF; Eberl, S; Fulham, M; Homewood, J; Knopman, AA; Mohamed, A; Somerville, E; Stevenson, RJ; Wen, L; Wong, CH | 1 |
| Ishii, K; Ishiwata, K; Kiyosawa, M; Murai, H; Suzuki, Y; Tokumaru, AM | 1 |
| Beer, AJ; Riepe, MW; Vonend, C; Walther, B | 1 |
| Bao, XJ; Lei, JF; Li, XY; Men, WW; Wang, RZ; Wang, ZJ; Zhu, H; Zhu, ZH; Zuo, FX | 1 |
| Lee, MJ; Lin, CH; Tai, CH; Wu, RM; Yen, KY; Yen, RF; Yip, PK | 1 |
| Akanuma, K; Ishii, H; Meguro, K; Meguro, M; Yamaguchi, S | 1 |
| Bleasel, A; Byth, K; Eberl, S; Fulham, M; Mohamed, A; Somerville, E; Wen, L; Wong, CH | 1 |
| Chang, KT; Cho, ZH; Heo, JH; Jang, DP; Lee, KM; Lee, SR; Lee, ST; Oh, JH | 1 |
| Binns, D; Cardamone, L; Hicks, RJ; Jones, N; Jupp, B; O'Brien, TJ; Rees, S; Williams, J | 1 |
| Ding, F; Feng, DF; Gu, L; Li, J; Rong, J; Zhu, G | 1 |
| Kawai, N; Kawanishi, M; Nagao, S; Tamiya, T | 1 |
| Cannella, M; Ciarmiello, A; Frati, L; Lastoria, S; Rubinsztein, DC; Simonelli, M; Squitieri, F | 1 |
| Boppana, M; de Leon, MJ; De Santi, S; Laska, E; Li, J; Li, Y; Mosconi, L; Rusinek, H; Tsui, WH | 1 |
1 trial(s) available for fluorodeoxyglucose f18 and Glucose Metabolic Disorder
| Article | Year |
|---|---|
Brain white-matter volume loss and glucose hypometabolism precede the clinical symptoms of Huntington's disease.
Topics: Adult; Atrophy; Brain; Cohort Studies; Female; Fluorodeoxyglucose F18; Glucose Metabolism Disorders; Humans; Huntington Disease; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Nerve Fibers, Myelinated; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity | 2006 |
14 other study(ies) available for fluorodeoxyglucose f18 and Glucose Metabolic Disorder
| Article | Year |
|---|---|
Evolution of Brain Glucose Metabolic Abnormalities in Children With Epilepsy and SCN1A Gene Variants.
Topics: Brain; Child; Child, Preschool; Epilepsy; Female; Fluorodeoxyglucose F18; Glucose Metabolism Disorders; Humans; Longitudinal Studies; Male; Mutation; NAV1.1 Voltage-Gated Sodium Channel; Positron-Emission Tomography; Retrospective Studies | 2018 |
Sporadic Creutzfeldt-Jakob disease with mesiotemporal hypermetabolism.
Topics: Aged; Basal Ganglia; Creutzfeldt-Jakob Syndrome; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Glucose Metabolism Disorders; Humans; Metabolic Diseases; Positron-Emission Tomography; Temporal Lobe | 2014 |
The relationship between neuropsychological functioning and FDG-PET hypometabolism in intractable mesial temporal lobe epilepsy.
Topics: Adolescent; Adult; Anterior Temporal Lobectomy; Attention; Epilepsy, Temporal Lobe; Female; Fluorodeoxyglucose F18; Frontal Lobe; Glucose Metabolism Disorders; Humans; Male; Memory; Memory Disorders; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Temporal Lobe; Treatment Outcome | 2015 |
Cerebral glucose metabolism in the striate cortex positively correlates with fractional anisotropy values of the optic radiation in patients with glaucoma.
Topics: Adult; Aged; Aged, 80 and over; Anisotropy; Blood Glucose; Case-Control Studies; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Glaucoma; Glucose Metabolism Disorders; Humans; Male; Middle Aged; Optic Nerve Diseases; Positron-Emission Tomography; Prospective Studies; Vision Disorders; Visual Cortex; Visual Field Tests; Visual Fields | 2015 |
Drug-induced cerebral glucose metabolism resembling Alzheimer's Disease: a case study.
Topics: Aged; Alzheimer Disease; Anticonvulsants; Antidepressive Agents; Attention; Cognition Disorders; Depressive Disorder, Major; Diagnosis, Differential; Drug Therapy, Combination; Essential Tremor; Fluorodeoxyglucose F18; Glucose Metabolism Disorders; Humans; Lithium Compounds; Male; Memory Disorders; Memory, Episodic; Mental Recall; Neuropsychological Tests; Positron-Emission Tomography; Primidone; Radiopharmaceuticals; Recurrence; Venlafaxine Hydrochloride | 2015 |
Age- and Brain Region-Specific Changes of Glucose Metabolic Disorder, Learning, and Memory Dysfunction in Early Alzheimer's Disease Assessed in APP/PS1 Transgenic Mice Using
Topics: Aging; Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Brain; Cognition; Disease Models, Animal; Female; Fluorodeoxyglucose F18; Glucose; Glucose Metabolism Disorders; Hippocampus; Humans; Maze Learning; Memory Disorders; Mice, Inbred C57BL; Mice, Transgenic; Mutation; Positron-Emission Tomography; Presenilin-1 | 2016 |
Focal brain glucose hypermetabolism in myoclonus-dystonia syndrome caused by an epsilon-sarcoglycan gene mutation.
Topics: Adult; Brain; Dystonic Disorders; Female; Fluorodeoxyglucose F18; Glucose; Glucose Metabolism Disorders; Humans; Mutation; Myoclonus; Pedigree; Sarcoglycans; Syndrome | 2009 |
Assessment of mental deterioration with the Cognitive Abilities Screening Instrument (CASI) and glucose hypometabolism in Alzheimer's disease: the Osaki-Tajiri Project.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Analysis of Variance; Brain; Brain Mapping; Cognition Disorders; Community-Based Participatory Research; Female; Fluorodeoxyglucose F18; Functional Laterality; Glucose Metabolism Disorders; Humans; Male; Mental Disorders; Mental Status Schedule; Neuropsychological Tests; Positron-Emission Tomography; Radiopharmaceuticals; Ultrasonography | 2009 |
The topography and significance of extratemporal hypometabolism in refractory mesial temporal lobe epilepsy examined by FDG-PET.
Topics: Adult; Anterior Temporal Lobectomy; Brain Mapping; Electroencephalography; Epilepsy, Temporal Lobe; Female; Fluorodeoxyglucose F18; Glucose Metabolism Disorders; Humans; Longitudinal Studies; Male; Positron-Emission Tomography; Retrospective Studies; Treatment Outcome; Young Adult | 2010 |
Spatial distribution of glucose hypometabolism induced by intracerebroventricular streptozotocin in monkeys.
Topics: Alzheimer Disease; Animals; Brain; Brain Mapping; Disease Models, Animal; Fluorodeoxyglucose F18; Glucose Metabolism Disorders; Injections, Intraventricular; Macaca fascicularis; Magnetic Resonance Imaging; Positron-Emission Tomography; Streptozocin; Time Factors | 2011 |
Hypometabolism precedes limbic atrophy and spontaneous recurrent seizures in a rat model of TLE.
Topics: Analysis of Variance; Animals; Atrophy; Brain Mapping; CA1 Region, Hippocampal; Disease Models, Animal; Disease Progression; Electroencephalography; Electron Transport Complex IV; Epilepsy, Temporal Lobe; Excitatory Amino Acid Agonists; Fluorodeoxyglucose F18; Glial Fibrillary Acidic Protein; Glucose Metabolism Disorders; Glucose Transporter Type 1; Kainic Acid; Limbic System; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Pyramidal Cells; Rats; Rats, Wistar; Synaptophysin; Time Factors | 2012 |
Exploring temporospatial changes in glucose metabolic disorder, learning, and memory dysfunction in a rat model of diffuse axonal injury.
Topics: Animals; Blood Glucose; Diffuse Axonal Injury; Fluorodeoxyglucose F18; Glucose Metabolism Disorders; Glycolysis; Hippocampus; Image Processing, Computer-Assisted; Learning Disabilities; Linear Models; Magnetic Resonance Imaging; Male; Maze Learning; Memory Disorders; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Tomography, X-Ray Computed | 2012 |
Crossed cerebellar glucose hypermetabolism demonstrated using PET in symptomatic epilepsy--case report.
Topics: Aged; Brain Injuries; Cerebellum; Cerebral Cortex; Epilepsy; Fluorodeoxyglucose F18; Glucose; Glucose Metabolism Disorders; Humans; Male; Positron-Emission Tomography; Radiopharmaceuticals | 2005 |
Hippocampal hypometabolism predicts cognitive decline from normal aging.
Topics: Aged; Aged, 80 and over; Aging; Cognition Disorders; Dementia; Female; Fluorodeoxyglucose F18; Glucose; Glucose Metabolism Disorders; Hippocampus; Humans; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Statistics as Topic | 2008 |